CZ103595A3 - Derivative of 3-indolylpiperidine, process of its preparation, its use for preparing a pharmaceutical preparation and and the pharmaceutical composition containing thereof - Google Patents

Derivative of 3-indolylpiperidine, process of its preparation, its use for preparing a pharmaceutical preparation and and the pharmaceutical composition containing thereof

Info

Publication number
CZ103595A3
CZ103595A3 CZ951035A CZ103595A CZ103595A3 CZ 103595 A3 CZ103595 A3 CZ 103595A3 CZ 951035 A CZ951035 A CZ 951035A CZ 103595 A CZ103595 A CZ 103595A CZ 103595 A3 CZ103595 A3 CZ 103595A3
Authority
CZ
Czechia
Prior art keywords
preparation
pharmaceutical
indolylpiperidine
derivative
preparing
Prior art date
Application number
CZ951035A
Other languages
English (en)
Other versions
CZ285369B6 (cs
Inventor
Henning Dr Bottcher
Joachim Dr Marz
Christoph Dr Seyfried
Hartmut Dr Greiner
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CZ103595A3 publication Critical patent/CZ103595A3/cs
Publication of CZ285369B6 publication Critical patent/CZ285369B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CZ951035A 1994-04-22 1995-04-21 Derivát 3-indolylpiperidinu, způsob jeho přípravy, jeho použití pro přípravu farmaceutického prostředku a farmaceutický prostředek, který ho obsahuje CZ285369B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4414113A DE4414113A1 (de) 1994-04-22 1994-04-22 3-Indolylpiperidine

Publications (2)

Publication Number Publication Date
CZ103595A3 true CZ103595A3 (en) 1995-12-13
CZ285369B6 CZ285369B6 (cs) 1999-07-14

Family

ID=6516183

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ951035A CZ285369B6 (cs) 1994-04-22 1995-04-21 Derivát 3-indolylpiperidinu, způsob jeho přípravy, jeho použití pro přípravu farmaceutického prostředku a farmaceutický prostředek, který ho obsahuje

Country Status (20)

Country Link
US (1) US5693655A (cs)
EP (1) EP0683166B1 (cs)
JP (1) JPH07291969A (cs)
KR (1) KR100361950B1 (cs)
CN (1) CN1047385C (cs)
AT (1) ATE172730T1 (cs)
AU (1) AU697749B2 (cs)
CA (1) CA2147451C (cs)
CZ (1) CZ285369B6 (cs)
DE (2) DE4414113A1 (cs)
DK (1) DK0683166T3 (cs)
ES (1) ES2125508T3 (cs)
HU (1) HUT74096A (cs)
NO (1) NO307831B1 (cs)
PL (1) PL180781B1 (cs)
RU (1) RU2151148C1 (cs)
SK (1) SK280881B6 (cs)
TW (1) TW401416B (cs)
UA (1) UA41333C2 (cs)
ZA (1) ZA953260B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
GB9523462D0 (en) * 1995-11-16 1996-01-17 Merck Sharp & Dohme Therapeutic agents
ZA9711376B (en) 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
DE19707628A1 (de) * 1997-02-26 1998-08-27 Merck Patent Gmbh Oxazolidinone
ES2206963T3 (es) 1997-07-25 2004-05-16 H. Lundbeck A/S Derivados de indol y de 2,3-dihidroindol, su preparacion y uso.
IL133960A0 (en) * 1997-08-15 2001-04-30 Pfizer Prod Inc 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6291467B1 (en) 1998-03-18 2001-09-18 Taisho Pharmaceutical Co., Ltd. Heteroaromatic derivatives
WO1999047515A1 (fr) * 1998-03-19 1999-09-23 Nihon Nohyaku Co., Ltd. Derives d'arylpiperidine et utilisation de ceux-ci
US6310066B1 (en) 1998-04-29 2001-10-30 American Home Products Corp. Antipsychotic indolyl derivatives
US6204274B1 (en) 1998-04-29 2001-03-20 American Home Products Corporation Indolyl derivatives as serotonergic agents
PL344978A1 (en) 1998-06-19 2001-11-19 Lundbeck & Co As H 4,5,6 and 7-indole and indoline derivatives, their preparation and use
US6066637A (en) * 1998-06-19 2000-05-23 American Home Products Corporation Indolyl derivatives as serotonergic agents
CA2335711A1 (en) * 1998-06-19 1999-12-29 Ivan Mikkelsen 4,5,6 and 7-indole and indoline derivatives, their preparation and use
AR020773A1 (es) * 1998-10-16 2002-05-29 Duphar Int Res Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto
EP1200072A2 (en) * 1999-05-12 2002-05-02 Solvay Pharmaceuticals B.V. Method of treating psychotic disorders
AU772189B2 (en) 1999-08-23 2004-04-08 Solvay Pharmaceuticals B.V. New phenylpiperazines
US6806275B2 (en) 2000-09-13 2004-10-19 Nihon Nohyaku Co., Ltd. Arylpiperidine derivatives and use thereof
AR032712A1 (es) 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
US6903110B2 (en) 2001-07-25 2005-06-07 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
US7235569B2 (en) * 2003-05-02 2007-06-26 Wyeth Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use
WO2016192657A1 (en) 2015-06-03 2016-12-08 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2675801A (en) * 1954-04-20 Intramedbllary nail
FR2349331A1 (fr) * 1976-04-30 1977-11-25 Roussel Uclaf Nouveaux derives de 2,3 dihydro a/4-(3-indolyl) 1-piperidinyl/methyl 1,4-benzodioxin-2-methanol, un procede pour leur preparation et leur application comme medicaments
GB2044254B (en) 1979-01-26 1983-01-26 Wyeth John & Brother Ltd Piperidine derivatives
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
HU198036B (en) * 1983-08-22 1989-07-28 Hoechst Roussel Pharma Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
US5256673A (en) * 1983-11-25 1993-10-26 Merck Patent Gesellschaft Mit Beschrankter Haftung Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8531665D0 (en) * 1985-12-23 1986-02-05 Wyeth John & Brother Ltd Indole derivatives
JP2860688B2 (ja) * 1990-03-14 1999-02-24 第一製薬株式会社 インドール誘導体
FR2675801A1 (fr) 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
KR102044254B1 (ko) * 2018-01-18 2019-11-13 (주)우신에이펙 배광제어가 가능한 led 탐조등

Also Published As

Publication number Publication date
CA2147451A1 (en) 1995-10-23
DE59504032D1 (de) 1998-12-03
PL308287A1 (en) 1995-10-30
NO951529D0 (no) 1995-04-21
KR950032176A (ko) 1995-12-20
NO307831B1 (no) 2000-06-05
US5693655A (en) 1997-12-02
CN1114651A (zh) 1996-01-10
AU1648895A (en) 1995-11-02
RU2151148C1 (ru) 2000-06-20
SK280881B6 (sk) 2000-08-14
ES2125508T3 (es) 1999-03-01
NO951529L (no) 1995-10-23
CN1047385C (zh) 1999-12-15
UA41333C2 (uk) 2001-09-17
JPH07291969A (ja) 1995-11-07
SK50895A3 (en) 1995-11-08
HUT74096A (en) 1996-11-28
PL180781B1 (pl) 2001-04-30
CA2147451C (en) 2006-03-28
TW401416B (en) 2000-08-11
DK0683166T3 (da) 1999-07-12
KR100361950B1 (ko) 2003-02-05
HU9501139D0 (en) 1995-06-28
EP0683166A1 (de) 1995-11-22
AU697749B2 (en) 1998-10-15
EP0683166B1 (de) 1998-10-28
RU95106675A (ru) 1997-03-20
ZA953260B (en) 1996-01-09
DE4414113A1 (de) 1995-10-26
CZ285369B6 (cs) 1999-07-14
ATE172730T1 (de) 1998-11-15

Similar Documents

Publication Publication Date Title
CZ103595A3 (en) Derivative of 3-indolylpiperidine, process of its preparation, its use for preparing a pharmaceutical preparation and and the pharmaceutical composition containing thereof
ZA932168B (en) Naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
AU4616893A (en) New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them
HUT46664A (en) Process for producing new dihydropyridineamide derivatives and pharmaceutical compositions comprising these compounds
HUT68190A (en) Process for producing ergoline derivatives of serotoninergic activity
AU4746993A (en) Azetidine compounds
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
AU625238B2 (en) Anti-psychotic piperidylbenzimidazole compounds
HUT76480A (en) Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
GR3017280T3 (en) Aminoalkylchromones, process for their preparation and compositions containing them.
DE69505756D1 (de) Verfahren zur Herstellung von (-)-N-methyl-N-[4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-benzamid und ihr pharmazeutisch annehmbares Salz
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
AU4327293A (en) 9-aminopyridazino(4',5' : 3,4)pyrrolo(2,1-a)isoquinolines and their use in the preparation of pharmaceutical compositions
CA2071093A1 (fr) Derives de benzoate d'ethanolamine, leur procede de preparation et les compositions pharmaceutiques les renfermant
HUT60495A (en) Process for producing ergoline derivatives and pharmaceutical compositions comprising such compounds

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20060421